Rare diseases
Investigational molecules
Locations
Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
FranceStudy on the Effectiveness and Safety of Perampanel for Children with Epilepsy
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceStudy of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer
FranceStudy on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy
FranceStudy on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response
FranceStudy Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment
FranceStudy on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery
FranceStudy on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma
FranceStudy on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
